PubRank

N Vavra

Author PubWeight™ 25.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lymphoscintigraphy with 123I-labelled epidermal growth factor. Lancet 1991 1.37
2 Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol 1994 1.08
3 Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Br J Cancer 1993 1.04
4 Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol 1998 0.95
5 First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer 1993 0.93
6 Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 1990 0.88
7 Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer 1990 0.86
8 A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer 1994 0.86
9 Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma. Br J Obstet Gynaecol 1990 0.85
10 Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Res 1996 0.85
11 Radical lymphadenectomy in the primary carcinoma of the fallopian tube. Arch Gynecol Obstet 1993 0.84
12 Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer. Eur J Cancer Clin Oncol 1989 0.82
13 BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse allele-specific oligonucleotide hybridization. Clin Chem 1999 0.82
14 Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol Oncol 1997 0.81
15 [Ferritin level in newborn infants after prepartal iron medication]. Geburtshilfe Frauenheilkd 1991 0.79
16 Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation? Int J Radiat Oncol Biol Phys 1997 0.79
17 Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 1991 0.79
18 [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?]. Gynakol Rundsch 1990 0.78
19 In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinoma. Cancer 1993 0.78
20 Detection of an atypical invasive mole in an ectopic pregnancy by transvaginal color-flow Doppler. Am J Obstet Gynecol 1993 0.77
21 [PAP IV in pregnancy--a retrospective multicenter study]. Geburtshilfe Frauenheilkd 1991 0.77
22 [Value of irradiation alone of generally inoperable endometrial cancer with high dose rate iridium 192]. Geburtshilfe Frauenheilkd 1990 0.76
23 Ultrasonic Doppler flow studies of the uterine arteries in women with cervix cancer. Gynecol Obstet Invest 1991 0.76
24 [Surgery in the treatment concept of epithelial ovarian cancer]. Gynakol Rundsch 1990 0.76
25 Primary fallopian tube carcinoma--a retrospective survey of 51 cases. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Arch Gynecol Obstet 1994 0.75
26 Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube. Arch Gynecol Obstet 1994 0.75
27 Cervical assessment and preterm delivery. Lancet 1994 0.75
28 Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma. Arch Gynecol Obstet 1994 0.75
29 CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer 1998 0.75
30 Lymphoscintigraphy using epidermal growth factor as tumour-seeking agent in uterine cervical cancer. Wien Klin Wochenschr 1991 0.75
31 Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks. Gynecol Oncol 1995 0.75
32 [Surgical gynecologic interventions in females over 75 years of age]. Geburtshilfe Frauenheilkd 1986 0.75
33 [The CA-125 tumor marker in epithelial ovarian cancers of stage I]. Wien Klin Wochenschr 1993 0.75
34 [Primary fallopian tube cancer--an Austrian multicenter study]. Geburtshilfe Frauenheilkd 1993 0.75
35 [Breech presentation in primiparous patients: indications for primary Cesarean section?]. Gynakol Geburtshilfliche Rundsch 1992 0.75
36 [Breech presentation in nulliparous women--vaginal delivery or indications for primary section?]. Geburtshilfe Frauenheilkd 1993 0.75
37 [CA-12 tumor marker values in serum following radioimmuno-scintigraphy]. Gynakol Rundsch 1990 0.75
38 [Value of radical lymph node excision and postoperative therapy (chemotherapy vs. irradiation) in primary tubal cancer]. Gynakol Geburtshilfliche Rundsch 1994 0.75
39 [Ovarian cancer after hysterectomy]. Gynakol Geburtshilfliche Rundsch 1993 0.75
40 [Effect of various factors on survival after recurrent and/or metastatic breast cancer]. Geburtshilfe Frauenheilkd 1991 0.75
41 [Lymphoscintigraphy with (123)I-marked epidermal growth factor in cervix cancer]. Gynakol Geburtshilfliche Rundsch 1992 0.75
42 [Carboplatin, VP-16 in epithelial ovarian cancer--initial experiences]. Gynakol Rundsch 1988 0.75
43 [Isotope nephrogram in follow-up of radically operated cervix cancers]. Geburtshilfe Frauenheilkd 1993 0.75
44 [Cesarean section versus vaginal delivery of breech presentation in primiparous patients]. Gynakol Rundsch 1989 0.75
45 Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Oncol 1994 0.75
46 [The value of postoperative irradiation in endometrial cancer of pathohistologic stage I]. Geburtshilfe Frauenheilkd 1989 0.75
47 [Pap IV in pregnancy--a retrospective multicenter study]. Gynakol Rundsch 1990 0.75
48 DNA ploidy in primary fallopian-tube carcinoma using image cytometry. Int J Cancer 1994 0.75
49 -CA-125 antigen as a prognostic factor for survival in patients with epithelial ovarian carcinoma of FIGO stage I--preliminary results-. Geburtshilfe Frauenheilkd 1996 0.75
50 Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma. Cancer Lett 1995 0.75
51 [After-care and palliative therapeutic measures in ovarian carcinoma]. Wien Med Wochenschr 1996 0.75
52 [Ovarian cancer following hysterectomy]. Gynakol Rundsch 1989 0.75
53 [Primary irradiated adenocarcinoma of the uterine cervix]. Gynakol Rundsch 1989 0.75
54 [Color Doppler flow measurements in uterine cancers]. Ultraschall Med 1991 0.75
55 [High-dose epirubicin in combination with high-dose ifosfamide plus granulocyte colony stimulating factor in patients with advanced platin-pretreated ovarian cancer. Phase I-II study]. Gynakol Geburtshilfliche Rundsch 1993 0.75
56 [The prognostic effect of scintigraphy-guided lymphadenectomy in therapy of stage Ib cervix carcinoma]. Geburtshilfe Frauenheilkd 1995 0.75
57 -Inguinal irradiation versus no lymph node therapy in small vulvar carcinoma with clinically negative lymph nodes (T1, NO-1)-. Gynakol Geburtshilfliche Rundsch 1995 0.75
58 [Vaginal sonography of the cervix in twin pregnancies]. Geburtshilfe Frauenheilkd 1994 0.75
59 [Conization in pregnancy and its significance for the further course of pregnancy]. Geburtshilfe Frauenheilkd 1991 0.75
60 [Survival prognosis in ovarian carcinoma Figo stages III and IV: 1980-1985 versus 1986-1993. A comparison of 2 treatment periods]. Gynakol Geburtshilfliche Rundsch 1997 0.75
61 [Fallopian tube cancer--an Austrian multicenter study]. Gynakol Geburtshilfliche Rundsch 1992 0.75
62 [Ca 125 in epithelial ovarian cancers of FIGO stage I]. Gynakol Geburtshilfliche Rundsch 1993 0.75
63 [Recombinant alpha and/or gamma interferon in the treatment of 45 patients with condylomata acuminata]. Gynakol Rundsch 1989 0.75
64 [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma]. Wien Klin Wochenschr 1990 0.75
65 [A risk score for surgically treated stage Ib cervix carcinoma and its significance for postoperative irradiation]. Wien Klin Wochenschr 1990 0.75
66 Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomised study with two schedules of granulocyte-macrophage colony stimulating factor. Eur J Cancer 1998 0.75
67 [Effect of radiation therapy on urodynamic parameters in cervix cancer patients]. Gynakol Rundsch 1991 0.75
68 [A risk score for operated endometrial cancer and its importance for adjuvant radiotherapy (histopathology and results of treatment based on 208 cases with pelvic lymph node excision)]. Geburtshilfe Frauenheilkd 1991 0.75
69 Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patients. Ann Oncol 1993 0.75
70 Influence of inflammatory reaction in primary fallopian-tube carcinoma (stage-I and stage-ii). Oncol Rep 1994 0.75
71 [PAP IV in pregnancy]. Gynakol Geburtshilfliche Rundsch 1992 0.75
72 [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer]. Wien Klin Wochenschr 1993 0.75
73 [Supportive measures for cytostatic therapy of gynecologic cancers]. Gynakol Rundsch 1991 0.75
74 [The value of surgical staging in the early stages of ovarian carcinoma]. Wien Klin Wochenschr 1990 0.75
75 [Isotope nephrography in follow-up of cervix cancer patients after radical surgery]. Gynakol Rundsch 1991 0.75
76 Reproductive performance after local and systemic prostaglandin for ectopic pregnancy. Arch Gynecol Obstet 1992 0.75